![Tetrabenazine D6 - CAS# 1392826-25-3 Catalog No.:M11057-10 1'-biphenyl]-3-yl)methoxy)-2](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M11057_1621562916.gif?v=1742890162)
Pay in 4 interest-free payments of $43.88 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
1'-biphenyl]-3-yl)methoxy)-2
6 versus placebo percentage points when added to metformin
that is currently under evaluation in human clinical trials for the treatment of acute severe pain
Multitargeted receptor tyrosine kinase inhibitor MP470 binds to mutant forms of the stem cell factor receptor (c-Kit
Tetrabenazine D6 - CAS# 1392826-25-3 Catalog No.:M11057-10 1'-biphenyl]-3-yl)methoxy)-2Deutetrabenazine, also known as SD 809 and Tetrabenazine d6, is an investigational, oral, small molecule inhibitor of vesicular monoamine 2 transporter, or VMAT2, that is designed to regulate the levels of a specific neurotransmitter, dopamine, in the brain. Deutetrabenazine is a deuterated tetrabenazine. SD 809 is being developed for the treatment of chorea associated with Huntingtons disease, a neurodegenerative movement disorder that impacts
US$ 4558.51
US$ 40.00
US$ 60.00
US$ 1449.50
US$ 337.50
US$ 52.00